Dr. Chao Wang | Gene Regulation Epigenetics | Research Excellence Award

Hangzhou First People’s Hospital | China

Dr. Chao Wang is a dedicated surgeon specializing in hepato-pancreato-biliary surgery and liver transplantation at The Affiliated Hangzhou First People’s Hospital, Zhejiang University. His expertise encompasses liver transplantation, hepatobiliary, and pancreatic surgery, with a strong focus on translational research integrating genetics and clinical outcomes. Dr. Wang has contributed extensively to understanding the role of donor gene polymorphisms, one-carbon metabolism, and molecular regulatory networks in post-transplant complications, hepatocellular carcinoma recurrence, and liver fibrosis. His publications span high-impact journals, exploring predictive models for transplant outcomes, immunosuppressive regimens, and novel molecular mechanisms such as the MAGI2-AS3/miRNA-374-5p/FOXO1 axis in HBV-related HCC. As a principal investigator and collaborator in multiple national and provincial research projects, he combines clinical practice with rigorous scientific investigation. Dr. Wang’s work advances personalized medicine in liver transplantation, providing valuable insights into genetic and molecular determinants of patient prognosis and post-operative management, reflecting a high h-index in his field.

Featured Publications